Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (002932.SZ)
CNY 18.84
(-0.37%)
CNY 18.84
(-0.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 439.81 Million CNY | -94.22% |
| 2022 | 7.03 Billion CNY | 231.59% |
| 2021 | 2.12 Billion CNY | 183.0% |
| 2020 | 750.1 Million CNY | 457.11% |
| 2019 | 134.64 Million CNY | -1.0% |
| 2018 | 135.99 Million CNY | 0.61% |
| 2017 | 135.17 Million CNY | 12.1% |
| 2016 | 120.58 Million CNY | 60.19% |
| 2015 | 75.27 Million CNY | 82.84% |
| 2014 | 41.16 Million CNY | 124.77% |
| 2013 | 18.31 Million CNY | 339.0% |
| 2012 | 4.17 Million CNY | 452.48% |
| 2011 | 755.2 Thousand CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 24.24 Million CNY | -76.82% |
| 2024 Q2 | 57.99 Million CNY | 139.17% |
| 2024 Q3 | 31.07 Million CNY | -45.92% |
| 2023 Q3 | 44.61 Million CNY | -52.24% |
| 2023 Q4 | 104.62 Million CNY | 134.53% |
| 2023 FY | 406.83 Million CNY | -94.22% |
| 2023 Q1 | 164.18 Million CNY | -91.21% |
| 2023 Q2 | 93.4 Million CNY | -43.11% |
| 2022 Q4 | 1.86 Billion CNY | 21.55% |
| 2022 Q2 | 1.79 Billion CNY | -2.19% |
| 2022 Q1 | 1.83 Billion CNY | 183.48% |
| 2022 FY | 7.03 Billion CNY | 231.59% |
| 2022 Q3 | 1.53 Billion CNY | -14.57% |
| 2021 Q1 | 518.97 Million CNY | 126.9% |
| 2021 Q3 | 602.85 Million CNY | 71.0% |
| 2021 Q2 | 352.55 Million CNY | -32.07% |
| 2021 Q4 | 648.41 Million CNY | 7.56% |
| 2021 FY | 2.12 Billion CNY | 183.0% |
| 2020 Q2 | 281.73 Million CNY | 1292.83% |
| 2020 Q4 | 228.72 Million CNY | 4.24% |
| 2020 FY | 750.1 Million CNY | 457.11% |
| 2020 Q1 | 20.22 Million CNY | -25.55% |
| 2020 Q3 | 219.42 Million CNY | -22.12% |
| 2019 Q2 | 43.1 Million CNY | 16.05% |
| 2019 Q1 | 37.14 Million CNY | 13.54% |
| 2019 FY | 134.64 Million CNY | -1.0% |
| 2019 Q4 | 27.16 Million CNY | -0.21% |
| 2019 Q3 | 27.22 Million CNY | -36.84% |
| 2018 Q2 | 47.18 Million CNY | 59.72% |
| 2018 Q1 | 29.54 Million CNY | -23.0% |
| 2018 FY | 135.99 Million CNY | 0.61% |
| 2018 Q4 | 32.71 Million CNY | 23.19% |
| 2018 Q3 | 26.55 Million CNY | -43.72% |
| 2017 FY | 135.17 Million CNY | 12.1% |
| 2017 Q1 | 30.48 Million CNY | -2.47% |
| 2017 Q3 | 26.86 Million CNY | -31.49% |
| 2017 Q4 | 38.36 Million CNY | 42.83% |
| 2017 Q2 | 39.2 Million CNY | 28.6% |
| 2016 Q3 | 31.25 Million CNY | 7.65% |
| 2016 FY | 120.58 Million CNY | 60.19% |
| 2016 Q1 | 29.03 Million CNY | 37.35% |
| 2016 Q4 | 31.25 Million CNY | 0.0% |
| 2016 Q2 | 29.03 Million CNY | 0.0% |
| 2015 Q2 | 16.49 Million CNY | -0.0% |
| 2015 Q4 | 21.13 Million CNY | 0.0% |
| 2015 FY | 75.27 Million CNY | 82.84% |
| 2015 Q1 | 16.49 Million CNY | 30.12% |
| 2015 Q3 | 21.13 Million CNY | 28.13% |
| 2014 Q1 | 7.77 Million CNY | 26.68% |
| 2014 Q3 | 12.67 Million CNY | 63.03% |
| 2014 Q4 | 12.67 Million CNY | 0.0% |
| 2014 Q2 | 7.77 Million CNY | 0.0% |
| 2014 FY | 41.16 Million CNY | 124.77% |
| 2013 Q4 | 6.13 Million CNY | 0.0% |
| 2013 Q2 | 3.01 Million CNY | 0.0% |
| 2013 Q3 | 6.13 Million CNY | 103.37% |
| 2013 FY | 18.31 Million CNY | 339.0% |
| 2013 Q1 | 3.01 Million CNY | 0.0% |
| 2012 FY | 4.17 Million CNY | 452.48% |
| 2011 FY | 755.2 Thousand CNY | 0.0% |